Tyrosine 665 is the second most abundant mutational target in the STAT5B SH2 domain (Fig 1A), with 53 blood cancer cases identified in the Munich Leukemia Laboratory database and 12 blood cancer cases reported in the COSMIC database (Table S1). Here, STAT5B is linked to hematopoietic and lymphoid system neoplasm.